You searched for COVID-19 Research - Page 2 of 4

Office of Health Economics

Leading intellectual authority on global health economics

Research & Publications
News & Insights
Education
Innovation Policy Prize

Latest Research & Publications

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies

2020 OHE Annual Report to the Charity Commission

Informal Carer Burden Series: OHE on behalf of Roche

Insight
April 2023

Caring about Carers: Improving Consideration of the Burden of Informal Caring in HTA

Insight
March 2023

Around The World in HTAs: Spain – Are We There Yet?

AfricaVaccines_GettyImages-1402515820_landscape

Bulletin
March 2023

March 2023

Past Event
Sponsored Webinar
March 2023

Informal Caring Burden in HTA Series: Webinar 3 – Capturing carer burden in HTA: what is the future?

Past Event
Sponsored Webinar
February 2023

Informal Caring Burden in HTA Series: Webinar 2 – How is carer burden captured in HTA, and what are some of the existing challenges?

Past Event
Sponsored Webinar
February 2023

Informal Caring Burden in HTA Series: Webinar 1 – What is carer burden and why is it important in HTA?

Insight
February 2023

Cost-effectiveness Analysis of Gene Therapies for Inherited Eye Disease: Are Current Discounting Approaches Too Short-sighted?

Bulletin
February 2023

February 2023

News
February 2023

Applications open for MSc Fellowship Programme 2023

Fishing on the lake at sunset. Fishing background.

Insight
February 2023

Fishing for Innovative Drugs with the ODRS: Potential Benefits and Challenges

News
January 2023

Professor Aidan Hollis wins first £40,000 OHE Policy Innovation Prize

Past Event
OHE Webinar
January 2023

The Value of Vaccines and Taskforces

Past Event
OHE Webinar
January 2023

Vaccines, Antivirals, Lockdowns and COVID: Lessons from the Pandemic

Past Event
OHE Webinar
January 2023

Insights From 2022 and Emerging Issues in 2023

Latest Research & Publications

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies

2020 OHE Annual Report to the Charity Commission

It Takes Two to Tango: When do Conditional Reimbursement Risk-Sharing Schemes Work for Both Parties?

Making Outcome-Based Payment a Reality in the NHS. Phase Two: Practical Considerations

All Publications

Filter results by

Caring about Carers: Improving Consideration of the Burden of Informal Caring in HTA

Incentivising New Antibiotics: Designing a Value-Based Delinked Pull Incentive Mechanism

Around The World in HTAs: Spain – Are We There Yet?

March 2023

Informal Caring Burden in HTA Series: Webinar 3 – Capturing carer burden in HTA: what is the future?

Informal Caring Burden in HTA Series: Webinar 2 – How is carer burden captured in HTA, and what are some of the existing challenges?

Informal Caring Burden in HTA Series: Webinar 1 – What is carer burden and why is it important in HTA?

Cost-effectiveness Analysis of Gene Therapies for Inherited Eye Disease: Are Current Discounting Approaches Too Short-sighted?

February 2023

Applications open for MSc Fellowship Programme 2023

Fishing for Innovative Drugs with the ODRS: Potential Benefits and Challenges

Professor Aidan Hollis wins first £40,000 OHE Policy Innovation Prize

The Value of Vaccines and Taskforces

Vaccines, Antivirals, Lockdowns and COVID: Lessons from the Pandemic

Insights From 2022 and Emerging Issues in 2023

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies